Companies List
>> Applied Biosystems Group
Applied Biosystems Inc serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. The Company focuses on basic research, commercial research (pharmaceutical and biotechnology) and standardized testing, including forensic human identification, paternity testing and food testing. Applied Biosystems Inc has an installed base of approximately 180,000 instrument systems in nearly 100 countries. Basic research includes work at university, government and other non-profit institutions that focus on uncovering the basic laws of nature and understanding human disease. Pharmaceutical and biotechnology companies use Applied Biosystems Inc products to discover and develop new drugs more effectively. Standardized testing customers require systems that produce precise results from a high volume of automated tests.
Official website:
www.appliedbiosystems.com
|
|
 |
|
USA stock market daily report by Millenium Traders (October 9, 2008, Thursday, 10.30 p.m. GMT), 9 October 2008
USA stock market daily report by Millenium Traders (October 8, 2008, Wednesday, 10.30 p.m. GMT), 8 October 2008
USA stock market daily report by Millenium Traders (October 7, 2008, Tuesday, 10.30 p.m. GMT), 7 October 2008
|
|
Verint Systems price target reduced, 7 December 2007
Thomas Weisel upgraded Intel to "overweight", 6 December 2007
UBS upgraded price target on Exxon Mobil to $96, 21 November 2007
|
|
|
|
|
|
 |
|
Indian stock market morning report by Keynote Capitals (October 10, 2008, Friday, 7.00 a.m. GMT), 10 October 2008
Indian stock market morning report by Keynote Capitals (October 8, 2008, Wednesday, 7.00 a.m. GMT), 8 October 2008
Indian stock market morning report by Keynote Capitals (October 7, 2008, Tuesday, 6.00 a.m. GMT), 7 October 2008
|
|
Keynote Capitals maintain "buy" recommendation on Pyramid Saimira Theatre, 5 February 2008
Keynote Capitals recommends to buy Euro Ceramics Ltd., 5 February 2008
Keynote Capitals recommends to buy Pyramid Saimira Theatre, 13 December 2007
|
|
|
|
|
|
 |
|
Russian stock market morning report by Veles Capital (October 8, 2008, Wednesday, 7.30 a.m. GMT), 8 October 2008
Russian stock market morning report by Veles Capital (October 7, 2008, Tuesday, 7.30 a.m. GMT), 7 October 2008
Russian stock market morning report by Veles Capital (October 6, 2008, Monday, 7.30 a.m. GMT), 6 October 2008
|
|
Veles Capital upgraded price target on Rosneft from $14.31 to $15.11, recommendation "buy" unchanged, 18 September 2008
Veles Capital set price target of $5.75 on NLMK, recommenation - "buy", 17 September 2008
Veles Capital reduced price target on Lukoil from $138.44 to $129.63, recommendation "buy" unchanged, 15 September 2008
|
|
|
|
|
|
